Viewing Study NCT02537457


Ignite Creation Date: 2025-12-24 @ 7:00 PM
Ignite Modification Date: 2026-02-19 @ 9:25 PM
Study NCT ID: NCT02537457
Status: COMPLETED
Last Update Posted: 2015-09-01
First Post: 2015-08-28
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Bioequivalence Study of Rivaroxaban
Sponsor: Bayer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Embolism, Atrial Fibrillation and Venous Thrombosis View
Keywords: